How Liquid Biopsies are Helping in Detection of Cancer Relapse?
Circulating tumor cells (CTCs) are a rare subset of cells found in the blood of cancer patients, functioning as a seed for metastasis. Identifying them early on with liquid biopsies can help determine the occurrence of relapse. At the AACR virtual conference, Dr. Alberto Bardelli, Dr. Caroline Dive, and Dr. Sarah-Jane Dawson discussed how CTCs can be used to identify tumor evolution and minimal residual disease.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02